Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chibby family member 2 (CBY2) is a protein that is highly expressed in mature testis and develops in elongating spermatids, where it is known as spermatid-associated protein (SPERT) or NURIT[5]. It contains a Chibby-like superfamily domain. While the precise function of CBY2 remains unclear, it is speculated—by analogy to Chibby (CBY1), which directly binds β-catenin and suppresses canonical WNT signaling—that CBY2 may play a regulatory role in cell differentiation, including inhibition of muscle cell development and possibly involvement in spermatogenesis[5]. To date, no drugs are known to target CBY2 and it is not recognized as a canonical therapeutic target. The function of CBY2 is not well-studied and most evidence is indirect, inferred through its similarity to other Chibby proteins. Chibby (CBY1) can suppress WNT signaling by binding β-catenin and retaining it in the cytoplasm, thus interfering with its transcriptional activity. CBY2 might similarly play a role in the regulation of WNT signaling, impacting various differentiation processes[5]. CBY2 is primarily noted for its high expression in testicular tissue, specifically associating with differentiating spermatids, and for its potential to inhibit myogenic differentiation when overexpressed in muscle cells[5]. No strong evidence links CBY2 to diseases or roles as a biomarker, therapeutic target, or safety risk. Its research status remains early and mainly descriptive.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chibby family member 2 (CBY2).